Phio Pharmaceuticals (PHIO) Debt Ratio (2020)
Phio Pharmaceuticals' (PHIO) quarterly Debt Ratio came in at 0.01 in Q4 2020, up 15.88% on a QoQ basis from 0.01 in Q3 2020.
Phio Pharmaceuticals (PHIO) Debt Ratio (2020) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 1 years of Debt Ratio data on file, last reported at 0.01 in Q4 2020.
- Quarterly Debt Ratio changed N/A year-over-year to 0.01 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 0.01 (changed N/A YoY) and the FY2020 annual result came in at 0.01, changed N/A from the prior year.
- Debt Ratio climbed to 0.01 in Q4 2020, from 0.01 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.01 in Q4 2020 to a low of 0.01 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |